Table 27 shows the analysis of the Cholesterol levels [Target ≤ 4 mmol/l] and Lipid Therapy [LipRx] status of individuals reported to have ever had a Myocardial Infarct or CABG/Angioplasty. Of 623 individuals, 34.8% were above target despite 90.8% receiving Lipid Therapy [with mean Total Cholesterol 4.8 mmol/l and 9.2% not on Lipid Rx at all!].
Table 27 Cardiac Disease and Anti-Lipid Rx [Adult Forms Only]
Any Infarct, CABG or StrokeChol | LipRx | N | % in Category | % | Mean Chol | Mean HDL | Mean TG | Mean LDL |
---|---|---|---|---|---|---|---|---|
Chol >4 | No | 20 | 9.2% | ![]() | 5.0 | 1.2 | 1.8 | 2.8 |
Yes | 197 | 90.8% | ![]() | 4.8 | 1.2 | 2.4 | 2.6 | |
Total | ![]() | 217 | ![]() | 34.8% | ![]() | ![]() | ![]() | ![]() |
Chol ≤4 | No | 22 | 5.4% | ![]() | 3.5 | 1.2 | 1.2 | 1.7 |
Yes | 384 | 94.6% | ![]() | 3.3 | 1.0 | 1.6 | 1.5 | |
Total | ![]() | 406 | ![]() | 65.2% | ![]() | ![]() | ![]() | ![]() |
![]() | 623 | ![]() | 100.0% | ![]() | ![]() | ![]() | ![]() |
Document download
This publication is available as a downloadable document.
Australian National Diabetes Information Audit & Benchmarking (ANDIAB) 2011 Final Report(PDF 559 KB)